Analysis of COVID-19 Outbreak in Iraq from the Perspective of Doctors Working in Iraqi Hospitals
International Journal of Infectious Diseases and Therapy
Volume 5, Issue 2, June 2020, Pages: 29-33
Received: Apr. 8, 2020; Accepted: Apr. 24, 2020; Published: May 15, 2020
Views 75      Downloads 42
Omar Muayad Abdulkareem Al-Naqeeb, Department of surgery, College of medicine, Al-Iraqia Univerity, Baghdad, Iraq
Article Tools
Follow on us
Background: The COVID-19 is an enveloped RNA enveloped beta coronavirus. In Iraq there were more than 700 cases officially reported for the period from February 24th 2020 to April 1st 2020 and the case fatality rate was 7.1%. This study aims to determine the most common clinical characteristics of patients who are confirmed as COVID-19 positive in Iraq, as well as to understand the underlying causes which make Iraq have one of the highest case-fatality rates in the world. Methods: A total of 128 doctors working in Iraqi hospitals participated in this study through answering a questionnaire that has been prepared for this purpose. The questionnaire included a set of questions related to the symptoms of the disease, hospital procedures, the level of these procedures and major obstacles. A total of 108 patients who were diagnosed with COVID-19 enrolled in this study to understand the clinical characteristics of COVID-19 in Iraq. Result: The most common symptoms of COVID-19 in Iraq were: fever (seen in 85.2% of patients), cough (55.6%), shortness of breath (31.5%), fatigue (27.8%), headache (7.4%), diarrhea (1.9%), and (9.3%) were asymptomatic. Initial chest X-rays were abnormal in (63%) and lymphopenia was seen in (72.2%). Most of the doctors (76.2%) complained from the unclear guidelines regarding COVID-19 screening and (17.7%) of suspected cases were not tested for COVID-19. Conclusion: The high fatality rate which seen in Iraq is related to the low level of awareness and late presentation of the patients, in addition to the limited number of the COVID-19 screening tests, unclear guidelines regarding the patients who should be enrolled for the COVID-19 testing, and finally, many of the suspected cases which were reported by doctors were not provided with the necessary tests to confirm the diagnosis. All these together contribute to high fatality rate.
COVID-19, CORONAVIRUS, Case Fatality Rate, Iraq
To cite this article
Omar Muayad Abdulkareem Al-Naqeeb, Analysis of COVID-19 Outbreak in Iraq from the Perspective of Doctors Working in Iraqi Hospitals, International Journal of Infectious Diseases and Therapy. Vol. 5, No. 2, 2020, pp. 29-33. doi: 10.11648/j.ijidt.20200502.12
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395: 565-74.
Iraqi Ministry of health. Official page on February 24th 2020 (
World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – March 11th 2020 (
Pneumonia of unknown cause — China: disease outbreak news. Geneva: World Health Organization, January 5th 2020 (
W. Guan, Z. Ni, Yu Huand their co-workers Clinical Characteristics of Coronavirus Disease 2019 in China. February 28th 2020. (
Centers for disease control and prevention. March 14th 2020 (
Ng, Marimuthu, Leo, and Lee.Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. February 18th 2020. (
REUTERS investigations (The former minister of health). Iraq’s healthcare system is in crisis. March 2nd 2020. (
Iraqi Ministry of health. Official page On April 1st 2020 (
Johns Hopkins Coronavirus Resource Center. On April 1st 2020 (
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDCWeekly. Accessed February 20th 2020. ( 9a9b-fea8db1a8f51).
Coronavirus disease 2019 (COVID-19): situation report — 36. Geneva: World Health Organization, February 25th 2020 (
World Health Organization. Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans (
LaFleur-Brooks M. Exploring Medical Language: A Student-Directed Approach (7th Ed.). St. Louis, Missouri, US: Mosby Elsevier. (2008).
Joseph R. Biggs PhD, Dong-Er Zhang PhD, Molecular Basis of Lymphoid and Myeloid Diseases, Molecular Pathology (Second Edition), (2018).
Katie M. Boes, Amy C. Durham, -Bone Marrow, Blood Cells, and the Lymphoid/Lymphatic System, in Pathologic Basis of Veterinary Disease (Sixth Edition), (2017).
Iraqi Ministry of health. Official page On March 17th 2020 (
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186